Dr. Rebecca B. Campen, MD

Dr. Campen practices at Campen Dermatology in Savannah, Georgia.

Dr. Campen's NPI, 1023086899, was assigned on March 9, 2006. Dr. Campen graduated from Medical College of Georgia in 1987. Dr. Campen holds Georgia license 031202.

Dr. Campen's primary practice is Campen Dermatology, at 5102 Paulsen St Bldg 4 Bldg 4, Savannah, GA 31405-4614. The practice phone is (912) 356-3604.

Dr. Campen's primary practice is Campen Dermatology in Savannah, Georgia. The medical group on file is Campen Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Campen practices. Vendor and product names are available with a free account.

Dermatology is Dr. Campen's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Campen is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Campen's licenses on file in 5 states: Georgia, Massachusetts, South Carolina, Louisiana and Michigan.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Campen treats.

CMS data shows 12,469 Medicare services from Dr. Campen across 26 procedure codes in 2024, for 1,541 Medicare patients. Medicare paid $448,756 for them. Every service was in an office.

CMS counts 1,541 Medicare patients who saw Dr. Campen in 2024. The largest group is 75 to 84, with 704 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 1% are also on Medicaid. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Campen's median patient age at 71, with 64% women.

In 2024, Dr. Campen wrote 1,901 Medicare Part D claims for 735 patients. 99% of them were for generic drugs. CMS names the drug for 1,773 of them, across 20 drugs with 11 or more claims each, at $32,778 in total drug cost. In 2023, CMS named 1,735 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Campen for performance year 2024, reported individually. Dr. Campen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 3,999 procedures of removal of skin lesions by Dr. Campen, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Campen. The most frequent topics are Adiposis Dolorosa and Biopsy.

CMS Open Payments shows 125 general payments to Dr. Campen from 25 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $968.

Dmand AI lists 1 award for Dr. Campen.

Dr. Campen graduated from Medical College of Georgia in 1987. Dr. Campen is a member of AAD.

Dr. Campen is in network with 11 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.